Clinical Trials Logo

Eczema clinical trials

View clinical trials related to Eczema.

Filter by:

NCT ID: NCT00666302 Completed - Dermatitis, Atopic Clinical Trials

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Start date: October 2002
Phase: Phase 4
Study type: Interventional

A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis

NCT ID: NCT00666159 Completed - Dermatitis, Atopic Clinical Trials

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Start date: December 2002
Phase: Phase 4
Study type: Interventional

Comparison of Protopic Ointment to Elidel Cream to assess the safety and efficacy in pediatric patients with Atopic Dermatitis

NCT ID: NCT00663364 Completed - Eczema Clinical Trials

Care of the Dry Skin With Physiogel AI Lotion® (W0156)

Start date: April 2008
Phase: N/A
Study type: Interventional

Dry skin is a physiological condition and is characterized in contrast to greasy skin by roughness, desquamation and lack of brightness of the skin surface. Subjectively, feelings of tension, burning and itching can occur. Dry skin needs special care due to its structural and functional characteristics.We monitor an application test the Dermatocosmetics Oilatum Physiogel AI Lotion and Physiogel Lotion. This is to be accomplished with patients having dry skin. The influence on the roughness of skin, desquamation, feeling of tingle, burning and itching should be documented. If sleep quality is disturbed by tingle or itch, this will be monitored, too.

NCT ID: NCT00660127 Completed - Atopic Dermatitis Clinical Trials

The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients

Start date: October 2007
Phase: N/A
Study type: Observational

The purpose of this research study is to assess whether seeing other people itch affects itch perception in patients with atopic dermatitis and healthy subjects.

NCT ID: NCT00654355 Completed - Atopic Dermatitis Clinical Trials

Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

Start date: April 2008
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.

NCT ID: NCT00646867 Completed - Contact Dermatitis Clinical Trials

Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis

Start date: February 2008
Phase: N/A
Study type: Interventional

To determine if Tetrix Cream, when applied to the skin lesions on patients with contact dermatitis, improves the symptoms of burning and itching.

NCT ID: NCT00616538 Completed - Atopic Dermatitis Clinical Trials

Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis

Start date: December 2006
Phase: Phase 4
Study type: Interventional

Novel therapies for AD that avoid immunosuppression and potential carcinogensis are needed. EpiCeram™ , a topical cream, represents a novel class of therapy for skin disorders that does not contain corticosteroids or other anti-inflammatory drugs. The objective of the present study is to demonstrate the safety and efficacy of EpiCeram ™ in the treatment of moderate to severe atopic dermatitis as compared to mid-strength topical steroid cream following twice daily dosing for four weeks in pediatric patients with AD. The potential benefit to patients lies in the potential for EpiCeram ™ to provide restoration of the normal skin barrier as shown in previous studies and eliminate or reduce the requirement for supplemental topical steroid administration.

NCT ID: NCT00616096 Completed - Dermatitis, Atopic Clinical Trials

Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether immunoadsorption is effective in the treatment of severe atopic dermatitis associated with excessively high serum IgE levels.

NCT ID: NCT00614731 Completed - Atopic Dermatitis Clinical Trials

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

Start date: December 2007
Phase: Phase 1
Study type: Interventional

Atopic dermatitis (AD) is a skin disorder in which people often have swelling and skin infections. People with this disease cannot receive the smallpox vaccine because it could cause them to have a fatal reaction known as eczema vaccinatum (EV). Keyhole limpet hemocyanin (KLH) is a protein that can be used to deliver vaccines to the body. The purpose of this study is to determine a baseline immune reaction to KLH in people without AD. Once this has been established, other studies can be designed to determine whether KLH can be used to give vaccines to people with AD.

NCT ID: NCT00614289 Completed - Contact Dermatitis Clinical Trials

Novel Topical Treatment of Hand Dermatitis (Eczema)

Start date: August 2006
Phase: Phase 1
Study type: Interventional

This study is designed as a prospective, randomized, double-blind right/left comparison of Epikeia coatings to improve hand dermatitis.